Cargando…

Implementation and utilization of the molecular tumor board to guide precision medicine

BACKGROUND: With rapid advances in genomic medicine, the complexity of delivering precision medicine to oncology patients across a university health system demanded the creation of a Molecular Tumor Board (MTB) for patient selection and assessment of treatment options. The objective of this report i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harada, Shuko, Arend, Rebecca, Dai, Qian, Levesque, Jessica A., Winokur, Thomas S., Guo, Rongjun, Heslin, Martin J., Nabell, Lisle, Nabors, L. Burt, Limdi, Nita A., Roth, Kevin A., Partridge, Edward E., Siegal, Gene P., Yang, Eddy S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5593688/ https://www.ncbi.nlm.nih.gov/pubmed/28915716 http://dx.doi.org/10.18632/oncotarget.18471

Ejemplares similares

Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples
por: Davis, Brittney H., et al.
Publicado: (2019)

Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
por: Limdi, Nita A.
Publicado: (2012)

Alchemy: A Web 2.0 Real-time Quality Assurance Platform for Human Immunodeficiency Virus, Hepatitis C Virus, and BK Virus Quantitation Assays
por: Agosto-Arroyo, Emmanuel, et al.
Publicado: (2017)

A Multimodal Evaluation of an Emergency Department Electronic Tracking Board Utility Designed to Optimize Stretcher Utilization
por: Chisholm, Dirk, et al.
Publicado: (2020)

The fuzzy world of precision medicine: deliberations of a precision medicine tumor board
por: McGraw, Sarah A, et al.
Publicado: (2017)

Geographical and Racial Disparities in Head and Neck Cancer Diagnosis in South-Eastern United States: Using Real-World Electronic Medical Records Data
por: Mukherjee, Amrita, et al.
Publicado: (2020)

Prognostic significance of thyroid or cricoid cartilage invasion in laryngeal or hypopharyngeal cancer treated with organ preserving strategies
por: Wagner, Marcus M, et al.
Publicado: (2012)

Mutations in Homologous Recombination Genes and Loss of Heterozygosity Status in Advanced-Stage Breast Carcinoma †
por: Bartow, Brooke B., et al.
Publicado: (2023)

Traditional risk factors and cancer-related factors associated with cardiovascular disease risk in head and neck cancer patients
por: Mukherjee, Amrita, et al.
Publicado: (2023)

Precision Medicine and the Institutional Review Board: Ethics and the Genome
por: Matrana, Marc R., et al.
Publicado: (2020)

Large Area Precision Cathode Boards for ATLAS Muon Upgrades
por: Shaked, Dan, et al.
Publicado: (2019)

National board governed post-graduate curriculum: Strengths and scope
por: Jadon, Ashok, et al.
Publicado: (2022)

Time to treatment initiation and its impact on real‐world survival in metastatic colorectal cancer and pancreatic cancer
por: Gbolahan, Olumide, et al.
Publicado: (2022)

ERBB2 mutation is associated with a worse prognosis in patients with CDH1 altered invasive lobular cancer of the breast
por: Ping, Zheng, et al.
Publicado: (2016)

Growth Factor Dependent Regulation of Centrosome Function and Genomic Instability by HuR
por: Filippova, Natalia, et al.
Publicado: (2015)

LPTO-01. LEPTOMENINGEAL METASTASIS FROM OVARIAN CARCINOMA TREATED WITH SYSTEMIC HIGH-DOSE METHOTREXATE
por: Coffee, Elizabeth, et al.
Publicado: (2019)

Molecular Tumour Board (MTB): From Standard Therapy to Precision Medicine
por: Ballatore, Zelmira, et al.
Publicado: (2023)

Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia
por: Malani, Disha, et al.
Publicado: (2022)

Evaluation of population‐level pharmacogenetic actionability in Alabama
por: Davis, Brittney H., et al.
Publicado: (2021)

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery
por: Bryce, Alan H., et al.
Publicado: (2017)

COVID-19, insurer board utility, and capital regulation
por: Li, Xuelian, et al.
Publicado: (2020)

Implementing precision oncology for sarcoma patients: the CCC(LMU)molecular tumor board experience
por: Berclaz, Luc M., et al.
Publicado: (2023)

Deployment of precise and robust sensors on board ISS—for scientific experiments and for operation of the station
por: Stenzel, Christian
Publicado: (2016)

Advancing molecular tumour boards: highly needed to maximise the impact of precision medicine
por: van de Haar, Joris, et al.
Publicado: (2019)

Pan-cancer molecular tumor board experience with biomarker-driven precision immunotherapy
por: Louie, Bryan H., et al.
Publicado: (2022)

Molecular Tumor Boards: The Next Step towards Precision Therapy in Cancer Care
por: Liu, Angela, et al.
Publicado: (2023)

An open-label, pilot study of veliparib and lapatinib in patients with metastatic, triple-negative breast cancer
por: Stringer-Reasor, Erica M., et al.
Publicado: (2021)

Family Nurse Practitioner Students’ Readiness for Board Certification Utilizing a Full Board Review Course and Simulation
por: Wolf, Lindsay, et al.
Publicado: (2023)

Utilization of Suberinic Acids Containing Residue as an Adhesive for Particle Boards
por: Makars, Raimonds, et al.
Publicado: (2022)

Glioblastoma Mimicking Viral Encephalitis Responds to Acyclovir: A Case Series and Literature Review
por: Piper, Keenan, et al.
Publicado: (2019)

Precision Medicine Tumor Boards: Clinical Applicability of Personalized Treatment Concepts in Ovarian Cancer
por: Aust, Stefanie, et al.
Publicado: (2020)

The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology
por: Tamborero, David, et al.
Publicado: (2022)

Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunich(LMU) Molecular Tumor Board
por: Dorman, Klara, et al.
Publicado: (2023)

The utilization of sugar cane bagasse for paper, board, plastic, and chemicals : an annotated bibliography
Publicado: (1952)

The Utilization of Autoantibodies in Approaches to Precision Health
por: Fritzler, Marvin J., et al.
Publicado: (2018)

Local Ancestry and Clinical Cardiovascular Events Among African Americans From the Atherosclerosis Risk in Communities Study
por: Shendre, Aditi, et al.
Publicado: (2017)

Race‐based and sex‐based differences in bioactive lipid mediators after myocardial infarction
por: Halade, Ganesh V., et al.
Publicado: (2020)

Precision Medicine and Heterogeneity of Treatment Effect in Therapies for ARDS
por: Khan, Yasin A., et al.
Publicado: (2021)

278 Eight Pharmacokinetic-related Genetic Variants Were Not Associated with Bleeding from Direct Oral Anticoagulants in Non-valvular Atrial Fibrillation Patients
por: Campos-Staffico, Alessandra M., et al.
Publicado: (2023)

Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patients
por: Campos-Staffico, Alessandra M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_890b92gv0bj340f3714cqvrqeb